Kimberly-Clark Buys Kenvue in $48.7B Deal that Forms Consumer Products Monolith
Kimberly-Clark Corp. said Monday that it has agreed to acquire Kenvue Inc. in a cash and stock deal that values the maker of Tylenol, which was spun off by Johnson & Johnson in 2023, at about $48.7 billion.
Kirkland & Ellis is Kimberly-Clark’s outside legal counsel and Grant McGee is the company’s general counsel. In-house lawyers for Kimberly-Clark who assisted McGee on the deal included vice president and deputy general counsel Courtney Roane on M&A activities and vice president and deputy general counsel Suzana Blades on litigation matters, as well as vice president, deputy general counsel and chief compliance officer Adam Crawford on regulatory matters.












